Design of pH-responsive antimicrobial peptide melittin analog-camptothecin conjugates for tumor therapy

Asian J Pharm Sci. 2024 Feb;19(1):100890. doi: 10.1016/j.ajps.2024.100890. Epub 2024 Feb 14.

Abstract

Melittin, a classical antimicrobial peptide, is a highly potent antitumor agent. However, its significant toxicity seriously hampers its application in tumor therapy. In this study, we developed novel melittin analogs with pH-responsive, cell-penetrating and membrane-lytic activities by replacing arginine and lysine with histidine. After conjugation with camptothecin (CPT), CPT-AAM-1 and CPT-AAM-2 were capable of killing tumor cells by releasing CPT at low concentrations and disrupting cell membranes at high concentrations under acidic conditions. Notably, we found that the C-terminus of the melittin analogs was more suitable for drug conjugation than the N-terminus. CPT-AAM-1 significantly suppressed melanoma growth in vivo with relatively low toxicity. Collectively, the present study demonstrates that the development of antitumor drugs based on pH-responsive antimicrobial peptide-drug conjugates is a promising strategy.

Keywords: Antimicrobial peptide; Antitumor activity; Cell-penetrating activity; Membrane disruption; Peptide-drug conjugate.